InfuSystem (NYSEAMERICAN:INFU) posted its earnings results on Tuesday. The medical instruments supplier reported ($0.03) EPS for the quarter, Morningstar.com reports. InfuSystem had a negative return on equity of 1.06% and a negative net margin of 0.73%.
InfuSystem (INFU) opened at $2.36 on Wednesday. The stock has a market capitalization of $49.55, a price-to-earnings ratio of -16.86 and a beta of 0.15. InfuSystem has a 52 week low of $1.20 and a 52 week high of $2.45.
InfuSystem declared that its board has initiated a share buyback program on Tuesday, March 13th that permits the company to repurchase 1,000,000 outstanding shares. This repurchase authorization permits the medical instruments supplier to purchase shares of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s board of directors believes its stock is undervalued.
InfuSystem Company Profile
InfuSystem Holdings, Inc is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada.
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.